ATAI Life Sciences

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue
$273
$0
$18
$87
Gross Profit
191
-83
-83
13
EBITDA
-25,647
-23,902
-33,460
-26,834
EBIT
-25,729
-23,985
-33,561
-26,908
Net Income
-57,312
-26,713
-18,292
44,244
Net Change In Cash
273
0
18
87
Free Cash Flow
-16,072
-22,578
-21,110
-18,433
Cash
34,333
23,867
45,034
76,492
Basic Shares
160,387
158,891
158,842
155,792

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$314
$233
$20,376
$19,880
Gross Profit
-5
65
20,329
-24
EBITDA
-125,152
-144,073
-104,845
-98,467
EBIT
-125,471
-144,241
-104,892
-98,491
Net Income
-40,224
-141,411
-132,612
-102,118
Net Change In Cash
314
233
20,376
19,880
Cost of Revenue
-170,530
Free Cash Flow
-84,708
-105,491
-64,374
-20,825
Cash
45,034
190,613
362,266
97,246
Basic Shares
158,833
155,719
160,677
5,813

Earnings Calls

Quarter EPS
2024-06-30
-$0.36
2024-03-31
-$0.17
2023-12-31
-$0.12
2023-09-30
-$0.28